Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Vanda Pharmaceuticals Stock News

VNDANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Vanda Pharmaceuticals (VNDA) Forecast

News

Earnings Vanda Pharmaceuticals (VNDA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Vanda Pharmaceuticals Stock News | NASDAQ:VNDA | Benzinga

Get the latest news on Vanda Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Vanda Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, April 23, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - 1 day ago
Vanda Pharma Says FDA Bureaucrats Unlawfully ...
Benzinga Newsdesk - 1 day ago

Tuesday, April 01, 2025

Forecasting The Future: 5 Analyst Projections For Vanda Pharmaceuticals
Benzinga Insights - Apr 1, 2025, 10:01AM
HC Wainwright & Co. Reiterates Buy on Vanda P...
Benzinga Newsdesk - Apr 1, 2025, 7:47AM

Monday, March 31, 2025

Vanda Pharmaceuticals Submits An NDA To The F...
Benzinga Newsdesk - Mar 31, 2025, 8:17AM

Monday, February 24, 2025

Vanda Pharmaceuticals Unveils Potential ASO T...
Benzinga Newsdesk - Feb 24, 2025, 7:05AM

Tuesday, February 18, 2025

The Analyst Verdict: Vanda Pharma In The Eyes Of 5 Experts
Benzinga Insights - Feb 18, 2025, 7:00AM
HC Wainwright & Co. Maintains Buy on Vanda Ph...
Benzinga Newsdesk - Feb 18, 2025, 6:51AM

Thursday, February 13, 2025

Vanda Pharma Sees FY2025 Sales $210.000M-$250...
Benzinga Newsdesk - Feb 13, 2025, 4:03PM
Vanda Pharma Q4 EPS $(0.08) Beats $(0.11) Est...
Benzinga Newsdesk - Feb 13, 2025, 4:02PM
Earnings Scheduled For February 13, 2025
Benzinga Insights - Feb 13, 2025, 3:32AM

Tuesday, February 04, 2025

HC Wainwright & Co. Reiterates Buy on Vanda P...
Benzinga Newsdesk - Feb 4, 2025, 7:02AM

Monday, February 03, 2025

Vanda Pharmaceuticals And Anaptys Announce Ex...
Benzinga Newsdesk - Feb 3, 2025, 7:36AM

Tuesday, January 28, 2025

A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts
Benzinga Insights - Jan 28, 2025, 8:01AM
HC Wainwright & Co. Reiterates Buy on Vanda P...
Benzinga Newsdesk - Jan 28, 2025, 7:07AM

Monday, January 27, 2025

Vanda Pharmaceuticals Accepts FDA's Offer Of ...
Benzinga Newsdesk - Jan 27, 2025, 7:06AM

Thursday, January 16, 2025

FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
Vandana Singh - Jan 16, 2025, 1:47PM

Wednesday, January 08, 2025

Vanda Pharmaceuticals Pens Letter To FDA Comm...
Benzinga Newsdesk - Jan 8, 2025, 4:23PM

Monday, December 23, 2024

HC Wainwright & Co. Reiterates Buy on Vanda P...
Benzinga Newsdesk - Dec 23, 2024, 6:51AM

Wednesday, November 06, 2024

Vanda Pharma Q3 2024 GAAP EPS $(0.09) Beats $...
Benzinga Newsdesk - Nov 6, 2024, 4:15PM
Vanda Pharma Raises FY2024 Sales Guidance fro...
Benzinga Newsdesk - Nov 6, 2024, 4:09PM

Friday, November 01, 2024

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
Vandana Singh - Nov 1, 2024, 2:05PM

Thursday, October 31, 2024

HC Wainwright & Co. Initiates Coverage On Van...
Benzinga Newsdesk - Oct 31, 2024, 8:01AM

Monday, October 14, 2024

Vanda Pharmaceuticals Confirms Receipt Of Uns...
Benzinga Newsdesk - Oct 14, 2024, 10:58AM
Vanda Pharmaceuticals shares are trading high...
Benzinga Newsdesk - Oct 14, 2024, 8:21AM
Cycle Pharmaceuticals Reaffirms Proposal To A...
Benzinga Newsdesk - Oct 14, 2024, 8:20AM

Friday, September 20, 2024

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
Zacks - Sep 20, 2024, 3:23PM

Thursday, September 19, 2024

Evoke Pharma Reaffirms Its Commitment To Impr...
Benzinga Newsdesk - Sep 19, 2024, 2:23PM
FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
Vandana Singh - Sep 19, 2024, 10:33AM
The FDA Declined To Approve Vanda's New Drug ...
Benzinga Newsdesk - Sep 19, 2024, 7:02AM

Thursday, August 01, 2024

Cantor Fitzgerald Maintains Overweight on Van...
Benzinga Newsdesk - Aug 1, 2024, 12:57PM

Wednesday, July 31, 2024

Vanda Pharmaceuticals Reinstates Guidance; Se...
Benzinga Newsdesk - Jul 31, 2024, 4:52PM
Vanda Pharma Q2 2024 GAAP EPS $(0.08) Beats $...
Benzinga Newsdesk - Jul 31, 2024, 4:28PM

Thursday, July 11, 2024

Cantor Fitzgerald Initiates Coverage On Vanda...
Benzinga Newsdesk - Jul 11, 2024, 7:27AM

Monday, July 01, 2024

US District Court For The District Of Delawar...
Benzinga Newsdesk - Jul 1, 2024, 8:05AM

Thursday, June 27, 2024

What's Going On With Vanda Pharmaceuticals Shares Today?
Nabaparna Bhattacharya - Jun 27, 2024, 12:10PM
Vanda Pharmaceuticals Inc. shares are trading...
Benzinga Newsdesk - Jun 27, 2024, 9:02AM
Future Pak Late Wednesday Announced The Withd...
Benzinga Newsdesk - Jun 27, 2024, 9:02AM

Thursday, June 20, 2024

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor - Jun 20, 2024, 1:26PM
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Jun 20, 2024, 8:22AM
Vanda Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk - Jun 20, 2024, 7:49AM
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor - Jun 20, 2024, 5:29AM
Reported Wednesday, Vanda Pharmaceuticals Rej...
Benzinga Newsdesk - Jun 20, 2024, 1:49AM

Thursday, June 13, 2024

Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
Avi Kapoor - Jun 13, 2024, 10:17AM
Vanda Pharmaceuticals Receives Revised Unsoli...
Benzinga Newsdesk - Jun 13, 2024, 10:03AM
Vanda Pharmaceuticals shares are trading high...
Benzinga Newsdesk - Jun 13, 2024, 8:19AM
Future Pak Increases Cash Portion Of Its Offe...
Benzinga Newsdesk - Jun 13, 2024, 8:18AM

Thursday, June 06, 2024

S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
Avi Kapoor - Jun 6, 2024, 2:45PM
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor - Jun 6, 2024, 1:39PM
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
Avi Kapoor - Jun 6, 2024, 12:22PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved